Moderna (NASDAQ:MRNA) price targets draw attention as shares rally into short holiday week

Moderna, Inc. jumped 12.59% Friday to close at $67.27, snapping a stretch this week where traders mostly ignored pipeline optionality. The stock started the week at $63.96 and finished up $3.31 for the week. Most of that came Friday, when the shares rose $7.52.

Biotechnology · NASDAQ:MRNA · Stock Market
US futures edge lower ahead of Russell index reshuffle as chip stocks see selling

US stocks: After-hours chips slump overshadows gains ahead of jobs data

U.S. stocks finished Friday with the S&P 500 down 0.05% at 7,354.02, Nasdaq off 0.24% to 25,297.62, and the Dow lower by 0.09% at 51,876.11. The Russell 2000 added 0.1% Friday and booked a 1% gain for the week. Index losses looked modest under the surface.
27 June 2026
············
Moderna Rises After FDA Review Renews Optimism on mRNA Flu Shot

Moderna Rises After FDA Review Renews Optimism on mRNA Flu Shot

Moderna, Inc. shares jumped Tuesday after FDA staff reviewers said data on the company’s mFlusiva flu shot “may support effectiveness” in adults 65 and up. Moderna traded at $57.19, up about 9.7%. The stock hit an intraday high of $57.36 on nearly 6.8 million shares traded. SPDR S&P 500 ETF Trust slipped 0.4%, with Invesco QQQ Trust down 1.4%.
16 June 2026
·
Moderna Revenue Beat: Overseas Covid Shot Sales Jump, but $900 Million Charge Clouds the Turnaround

Moderna Revenue Beat: Overseas Covid Shot Sales Jump, but $900 Million Charge Clouds the Turnaround

Moderna Inc. topped first-quarter revenue forecasts Friday, with international Covid-19 vaccine sales outpacing what the U.S. market delivered—setting the biotech up for a stronger 2026 kickoff than many investors had penciled in. Revenue hit $389 million, a jump from $108 million the previous year, and of that, $311 million was generated outside the U.S.)
1 May 2026
·
Pfizer stock slips on ex-dividend day — what to watch ahead of Feb. 3 earnings

Pfizer stock slips on ex-dividend day — what to watch ahead of Feb. 3 earnings

Pfizer shares dropped roughly 1.9% to $25.62 Friday afternoon, underperforming the health-care sector as the stock went ex-dividend. The Health Care Select Sector SPDR Fund dipped about 0.5%, while the SPDR S&P 500 ETF Trust inched up around 0.1%. Merck slipped about 1%, and Moderna tumbled over 7%. Trading volume for Pfizer hit roughly 24.8 million shares.
23 January 2026
·····
Moderna (MRNA) stock jumps after-hours as CEO signals pullback in new vaccine trials

Moderna (MRNA) stock jumps after-hours as CEO signals pullback in new vaccine trials

Moderna shares surged 4.2% to $51.87 in after-hours trading Thursday, following an earlier jump of about 11% to $55.17 on heavy volume—more than 34 million shares changed hands. CEO Stephane Bancel told Bloomberg TV the company won’t invest in new late-stage vaccine trials, pointing to growing resistance from U.S. officials. He cautioned that the U.S. market is becoming less dependable. “You cannot make a return on investment if you don’t have access to the U.S. market,” Bancel said.
23 January 2026
··
1 2 3 4
Follow on Google News
Add as preferred source Open in Google News

US Stock Market Today Updates

MARKET CALENDAR

Key Events Today

The catalysts most likely to move markets.

#1

Warsh at Jackson Hole

Policy tone can move rates, USD, equities, gold and crypto simultaneously.

#2

Michigan sentiment

A weak final reading or elevated inflation expectations could pressure risk assets.

#3

Chicago PMI

A surprise versus 58.0 may alter the near-term manufacturing-growth narrative.

View full calendar
Times and estimates may change. Verify before trading.